Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques

[1]  N. Haigwood,et al.  Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge , 2021, Frontiers in Immunology.

[2]  N. Haigwood,et al.  Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development , 2020, Frontiers in Immunology.

[3]  B. Haynes,et al.  Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge. , 2020, Cell reports.

[4]  Daniel W. Kulp,et al.  Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance , 2018, Cell.

[5]  M. Cameron,et al.  Antibiotic-induced microbiome perturbations are associated with significant alterations to colonic mucosal immunity in rhesus macaques , 2019, Mucosal Immunology.

[6]  M. Trøseid,et al.  Probiotics to manage inflammation in HIV infection. , 2019, Current opinion in infectious diseases.

[7]  B. Haynes,et al.  Multiple roles for HIV broadly neutralizing antibodies , 2019, Science Translational Medicine.

[8]  Francesco Asnicar,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[9]  N. Haigwood,et al.  Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses. , 2019, Cell reports.

[10]  N. Haigwood,et al.  Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology , 2019, Journal of Virology.

[11]  P. Pandiyan,et al.  Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa , 2019, Front. Immunol..

[12]  Daniel W. Kulp,et al.  Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers , 2019, Immunity.

[13]  M. Gosalbes,et al.  Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study) , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  A. Aldovini,et al.  Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission. , 2019, Current immunology reviews.

[15]  Itai Sharon,et al.  Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features , 2018, Cell.

[16]  J. Garssen,et al.  Pro‐ and anti‐inflammatory effects of short chain fatty acids on immune and endothelial cells , 2018, European journal of pharmacology.

[17]  Larissa B. Thackray,et al.  Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections , 2018, Cell reports.

[18]  S. H. van der Burg,et al.  Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections , 2018, Front. Immunol..

[19]  S. Langevin,et al.  Antibiotic treatment disrupts bacterial communities in the colon and rectum of simian immunodeficiency virus-infected macaques , 2017, FEMS microbiology letters.

[20]  H. Liao,et al.  Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge , 2017, Journal of Virology.

[21]  G. Rossi,et al.  Probiotic supplementation promotes a reduction in T‐cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART‐treated HIV‐1‐positive patients , 2017, Immunity, inflammation and disease.

[22]  C. Scagnolari,et al.  Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study , 2016, International journal of molecular sciences.

[23]  G. Learn,et al.  Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques , 2016, Proceedings of the National Academy of Sciences.

[24]  Karen G. Dowell,et al.  Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition , 2016, Nature Medicine.

[25]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[26]  T. Hope,et al.  Th17 Cells Are Preferentially Infected Very Early after Vaginal Transmission of SIV in Macaques. , 2016, Cell host & microbe.

[27]  N. Haigwood,et al.  Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens , 2016, The Journal of Immunology.

[28]  E. Haddad,et al.  Enhancement of Microbiota in Healthy Macaques Results in Beneficial Modulation of Mucosal and Systemic Immune Function , 2016, The Journal of Immunology.

[29]  Z. Klase,et al.  IL-21 and Probiotic Therapy Improve TH17 Frequencies, Microbial Translocation, and Microbiome in ARV-Treated, SIV-Infected Macaques , 2015, Mucosal Immunology.

[30]  William A. Walters,et al.  Improved Bacterial 16S rRNA Gene (V4 and V4-5) and Fungal Internal Transcribed Spacer Marker Gene Primers for Microbial Community Surveys , 2015, mSystems.

[31]  J. Brenchley,et al.  Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the “Probio-HIV” Clinical Trial , 2015, PloS one.

[32]  D. Montefiori,et al.  Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge , 2015, PLoS pathogens.

[33]  Q. Sattentau,et al.  The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice , 2015, Clinical and Vaccine Immunology.

[34]  Greg Finak,et al.  COMPASS identifies T-cell subsets correlated with clinical outcomes , 2015, Nature Biotechnology.

[35]  Timothy L. Tickle,et al.  Biogeography of the intestinal mucosal and lumenal microbiome in the rhesus macaque. , 2015, Cell host & microbe.

[36]  T. Ndung’u,et al.  Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection , 2015, AIDS.

[37]  N. Sardesai,et al.  Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques , 2014, Proceedings of the National Academy of Sciences.

[38]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[39]  E. Rosenberg,et al.  Induction of Gag-Specific CD4 T Cell Responses during Acute HIV Infection Is Associated with Improved Viral Control , 2014, Journal of Virology.

[40]  N. Sardesai,et al.  DNA and Protein Co-Immunization Improves the Magnitude and Longevity of Humoral Immune Responses in Macaques , 2014, PloS one.

[41]  N. Haigwood,et al.  Improvement of antibody responses by HIV envelope DNA and protein co-immunization. , 2014, Vaccine.

[42]  N. Frahm,et al.  Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. , 2013, The Journal of infectious diseases.

[43]  Raphael Gottardo,et al.  Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial , 2013, PloS one.

[44]  Barbara M. Bakker,et al.  The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.

[45]  S. Reed,et al.  HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques. , 2013, Vaccine.

[46]  J. Arthos,et al.  Preferential HIV Infection of CCR6+ Th17 Cells Is Associated with Higher Levels of Virus Receptor Expression and Lack of CCR5 Ligands , 2013, Journal of Virology.

[47]  Jerome H. Kim,et al.  Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG , 2013, Proceedings of the National Academy of Sciences.

[48]  A. Lackner,et al.  Divergent Kinetics of Proliferating T Cell Subsets in Simian Immunodeficiency Virus (SIV) Infection: SIV Eliminates the “First Responder” CD4+ T Cells in Primary Infection , 2013, Journal of Virology.

[49]  C. Deming,et al.  Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. , 2013, The Journal of clinical investigation.

[50]  N. Sardesai,et al.  DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge , 2013, Proceedings of the National Academy of Sciences.

[51]  D. Weiner,et al.  DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells , 2012, Human vaccines & immunotherapeutics.

[52]  Guido Ferrari,et al.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial. , 2012, The New England journal of medicine.

[53]  D. Fuller,et al.  Therapeutic DNA Vaccine Induces Broad T Cell Responses in the Gut and Sustained Protection from Viral Rebound and AIDS in SIV-Infected Rhesus Macaques , 2012, PloS one.

[54]  Dina N. Kovarik,et al.  Co-Immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8+ T Cells , 2012, PloS one.

[55]  D. Montefiori,et al.  Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Recombinant Priming and Envelope Protein Boosting Elicits Localized, Mucosal IgA Immunity in Rhesus Macaques Correlated with Delayed Acquisition following a Repeated Low-Dose Rectal SIVmac251 Challenge , 2012, Journal of Virology.

[56]  J. Routy,et al.  Memory CCR6+CD4+ T Cells Are Preferential Targets for Productive HIV Type 1 Infection Regardless of Their Expression of Integrin β7 , 2011, The Journal of Immunology.

[57]  N. Haigwood,et al.  Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies , 2011, Journal of Virology.

[58]  Matthew S. Lewis,et al.  Profound early control of highly pathogenic SIV by an effector-memory T cell vaccine , 2011, Nature.

[59]  William A. Walters,et al.  Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample , 2010, Proceedings of the National Academy of Sciences.

[60]  Jerome H. Kim,et al.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.

[61]  L. Stamatatos,et al.  Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection. , 2009, Vaccine.

[62]  S. Sieg,et al.  Faculty Opinions recommendation of Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. , 2009 .

[63]  D. Barouch,et al.  Challenges in the development of an HIV-1 vaccine , 2008, Nature.

[64]  Barbra A. Richardson,et al.  Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses , 2007, Journal of Virology.

[65]  W. Ludwig,et al.  SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB , 2007, Nucleic acids research.

[66]  Gary J. Nabel,et al.  Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys , 2006, Science.

[67]  D. Price,et al.  CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[68]  L. Stamatatos,et al.  Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate , 2003, Journal of Virology.

[69]  Mary S. Wu,et al.  Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin from Escherichia coli Are Strong Adjuvants for DNA Vaccines , 2002, Journal of Virology.

[70]  Mary S. Wu,et al.  Induction of Mucosal Protection against Primary, Heterologous Simian Immunodeficiency Virus by a DNA Vaccine , 2002, Journal of Virology.

[71]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[72]  D. Fuller,et al.  Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. , 1995, Vaccine.